Bogni C, Segura M, Giraudo J, Giraudo A, Calzolari A, Nagel R
Departamento de Microbiología e Inmunología, Facultad de Ciencias Exactas, Físico, Químicas y Naturales, Universidad Nacional de Río Cuarto, Córdoba, Argentina.
Can J Vet Res. 1998 Oct;62(4):293-8.
An avirulent mutant, designated RC122, was derived from Staphylococcus aureus bovine mastitis strain RC108 after N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis. Mutant RC122, which was isolated on the basis of reduced colony size, showed diminished virulence in mice (LD50 of RC122: 3.1 x 10(10) cfu vs LD50 of RC108: 2.3 x 10(7) cfu). Mutant RC122 grew more slowly than its parental strain and showed decreased production of several exoproteins, such as alpha- and beta-hemolysin, DNAse and coagulase. The production of its capsule was induced only under in vivo growth conditions. Clearance studies performed in the mouse kidney revealed that the kinetics of disappearance of the mutant was similar to that of its parental strain. Protection experiments carried out by intraperitoneal administration in mice showed that mutant RC122 conferred a good degree of protection from challenge with homologous and heterologous strains.
一株无毒突变体,命名为RC122,是在N-甲基-N'-硝基-N-亚硝基胍诱变后从金黄色葡萄球菌牛乳腺炎菌株RC108衍生而来。基于菌落尺寸减小而分离出的突变体RC122在小鼠中显示出毒力减弱(RC122的半数致死量:3.1×10¹⁰ cfu,而RC108的半数致死量:2.3×10⁷ cfu)。突变体RC122的生长速度比其亲本菌株慢,并且几种外毒素的产生减少,如α-和β-溶血素、DNA酶和凝固酶。其荚膜的产生仅在体内生长条件下被诱导。在小鼠肾脏中进行的清除研究表明,突变体消失的动力学与其亲本菌株相似。通过在小鼠中腹腔注射进行的保护实验表明,突变体RC122对同源和异源菌株的攻击提供了良好程度的保护。